A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)
Clinical trial NCT00281697 · COMPLETED
Trial details
- NCT number
- NCT00281697
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2009-03-01
- Enrollment
- 684
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.